Case-Based Roundtable Meetings Spotlight: July 2, 2022

Roundtable Roundup: Polling Physicians on Use of Frontline Therapies in RCC

July 24, 2022

Clinical Articles

During separate virtual live events, Sandy T. Liu, MD, and Moshe Ornstein, MD, MA, discussed what treatment they would choose for a patient with clear cell renal cell carcinoma and the trial data available in this setting.

Powell Reviews Trials of PARP Inhibition in BRCA-Positive Ovarian Cancer

July 21, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Matthew Powell, MD, discussed trials supporting the use of the PARP inhibitors niraparib and olaparib for patients with BRCA-positive ovarian cancer.

Roundtable Discussion: Mohamed Analyzes Data for Understanding ES-SCLC Treatment

July 18, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Mohamed K. Mohamed, MD, PhD, discussed with participants the challenges of treating extensive-stage small cell lung cancer and their views of the CASPIAN and IMpower 133 trial results.